Trevigen, Inc. is an innovative biotechnology company focused on the development of products and technology for cancer research and genetic toxicology, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior. The company is located in the I-270 “Technology Corridor” in Gaithersburg, Maryland. Trevigen-brand research products are marketed via the Internet, journal advertising, direct mail, and telemarketing, giving Trevigen worldwide recognition among those in the area of cancer research. Distributor appointments have been made in the Americas, Europe, and the Pacific Rim. Trevigen also has in place supply agreements with major government and university medical research centers in order to make us a part of the growing areas of government research and pharmaceutical research. The company is the recipient of several SBIR grants from the National Institutes of Health, concerning technology development for the analysis of DNA damage.
Trevigen is more than a typical biotechnology company. We are a long-standing provider of quality reagents and kits for researchers investigating programmed cell death and DNA damage and repair. With the increasing attention being placed on 3-D culture including spheroids and organoids, Trevigen established the Organoid Research Lab (ORL) in 2016. The ORL lab grows organoid models used to develop and optimize matrices and reagents for organoid culture.
Trevigen Cell Assays, (TCA) a division of Trevigen, Inc., was established in 2008 to conduct contract research work for the pharmaceutical, biotechnology, government and academic segments of the research market. TCA specializes in designing and conducting assays for lead compound and genotoxic screening based on DNA damage and repair and cancer cell behavior. We are proud of the role that we play in pharmaceutical research and government research.
Choosing a biotechnology company that you can rely on for the products you need in cancer research, drug discovery, genetic toxicology and regenerative medicine is important. Our role in pharmaceutical research and government research are one phase of what we do. We are also here to provide the high quality matrices and kits to those small or individual facilities that are taking an active role in studying genetic toxicology, stem cells, and cancer cell behavior.
As always, Trevigen brand products are manufactured to the highest standards of quality and backed by expert technical support. We know the importance of providing these important biotechnology products with quality that exceeds industry standards. Our reputation as a biotechnology company is important to us and we strive to always maintain an inventory of those products which provide the highest levels of performance.
TRADEMARKS: CometAssay, CometChip CultreCoat, Cultrex, PathClear, TACS, TACS•XL, and Trevigen, are registered trademarks, and 3-D Matrix, Apoptosis Grade, CardioTACS, CometSlide, Cytonin, Cytonin IHC, DePsipher, DermaTACS, DIVAA, FLARE, FlowTACS, NeuroPore, NeuroTACS, PeroxyGlow, REC, TACS Blue Label, TACS-Nuclease, TACS-Sapphire, TiterTACS, TumorTACS, and VasoTACS are trademarks of Trevigen, Inc.